Asia-pacific Autoimmune Disease Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

1. INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Public Awareness about Autoimmune Diseases
  • 4.2.2 Partnerships with Physicians and Clinical Laboratories
  • 4.2.3 Technological Advancements
• 4.3 Market Restraints
  • 4.3.1 Slow Turnaround Time for Autoimmune Disease Diagnostic Test Results
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

• 5.1 By Disease Type
  • 5.1.1 Systemic Autoimmune Disease
  • 5.1.1.1 Rheumatoid Arthritis
  • 5.1.1.2 Psoriasis
  • 5.1.1.3 Systemic Lupus Erythematosus (SLE)
  • 5.1.1.4 Multiple Sclerosis
  • 5.1.1.5 Other Systemic Autoimmune Diseases
  • 5.1.2 Localized Autoimmune Disease
  • 5.1.2.1 Inflammatory Bowel Disease
  • 5.1.2.2 Type 1 Diabetes
  • 5.1.2.3 Thyroid
  • 5.1.2.4 Other Localized Autoimmune Diseases
• 5.2 By Diagnosis
  • 5.2.1 Regular Laboratory Tests
  • 5.2.2 Inflammatory Markers
  • 5.2.3 Immunologic Assays
  • 5.2.4 Antibody Tests
  • 5.2.5 Other Tests
• 5.3 Geography
  • 5.3.1 Asia-Pacific
  • 5.3.1.1 China
  • 5.3.1.2 Japan
  • 5.3.1.3 India
  • 5.3.1.4 Australia
  • 5.3.1.5 South Korea
  • 5.3.1.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Abbott Laboratories
  • 6.1.2 BioMerieux
  • 6.1.3 Bio-Rad Laboratories, Inc.
  • 6.1.4 F. Hoffmann-La Roche Ltd
  • 6.1.5 PerkinElmer, Inc.
  • 6.1.6 Siemens AG
  • 6.1.7 Trinity Biotech
  • 6.1.8 Thermo Fisher Scientific
• *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS